A study in humans demonstrated that the mir-125b is dysregulated in burn injury, wound healing, and scarring processes, with its expression in human skin tissue and fibroblasts showing both upregulation and downregulation at specific post-burn timepoints [Siu et al. DOI:10.1111/wrr.13100]. In human myocardial infarction, circulating levels of the mir-125b were significantly decreased in patient plasma compared to healthy controls, as validated by next-generation sequencing and RT-qPCR, identifying it as a potential diagnostic biomarker [Baulina et al. DOI:10.1016/j.yjmcc.2018.07.129]. A study in humans identified the mir-125b as a potential body fluid identification marker for saliva, as reported in published data [Liu et al. DOI:10.3390/genes13091530].